AHG Overview

Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace.

Wall Street analysts forecast AHG stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHG is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Akso Health Group revenue for the last quarter amounts to NaN USD, decreased

Akso Health Group. EPS for the last quarter amounts to USD, decreased

Akso Health Group (AHG) has 27 emplpoyees as of May 11 2026.

Today AHG has the market capitalization of 1.70B USD.